Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Regulatory T-cells in Systemic Sclerosis
NCT05214014Phase 2Unknown
- Start
- Sep 2022
- Primary completion
- Dec 2023
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous regulatory T cells in systemic sclerosis (SSc). Status: unknown.
02
Drugs
autologous regulatory T cells
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT05214014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05214014.